MRVI Maravai LifeSciences Holdings,
$8.26▲ +8.97%
Healthcare
Other
After hours
$8.28▲ +0.24%
Oct 27, 5:50 PM ET
Volume 3.07M
Avg Volume (10D) 2.34M
Key Metrics & Fundamentals
Market Cap
$3.06B
P/E Ratio
–
Div Yield
0.00%
52W Range
2.55 - 9.42
% vs 50 MA
11.21%
% vs 200 MA
59.74%
RSI-14
61.1
MACD Histogram
+0.0800
Beta (1Y vs SPY)
1.46
Free Cash Flow
$3.62M
Gross Rev
$51.44M
Gross Profit
$20.65M
EBITDA
-$608,000
COGS
$30.79M
Operating Exp
$35.77M
Operating Income
-$15.12M
EBIT
-$15.12M
Pretax Income
-$21.80M
Net Income
-$12.42M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Is Maravai LifeSciences Holdings (MRVI) Priced Too Highly For Its Sales?
Simply Wall St. · Oct 27, 2026 1:14 AM ET
Maravai LifeSciences (MRVI) Stock Gets Fair Value Boost On mRNA And CleanCap Optimism
Simply Wall St. · Oct 17, 2026 6:10 AM ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
Business Wire · Oct 14, 2026 4:01 PM ET
TD Cowen Initiates Maravai Lifesciences at Buy With $9 Price Target
MT Newswires · Oct 5, 2026 6:31 AM ET
What Is Maravai’s (MRVI) Comeback Really Worth to Investors?
Insider Monkey · Oct 4, 2026 3:26 PM ET
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP
Business Wire · Sep 29, 2026 4:01 PM ET
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
Zacks · Sep 25, 2026 6:34 AM ET
Is Maravai LifeSciences Holdings (MRVI) Cheap If Cash Flow Recovers?
Simply Wall St. · Sep 25, 2026 5:09 AM ET
Maravai LifeSciences Holdings (MRVI) Rebounded Sharply, Is The Upside Already Priced In?
Simply Wall St. · Sep 24, 2026 11:12 AM ET
UBS Adjusts Maravai Lifesciences Price Target to $8 From $2.50, Maintains Neutral Rating
MT Newswires · Sep 9, 2026 9:37 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MRVI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.